{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:46:32Z","timestamp":1778078792111,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY22H180001"],"award-info":[{"award-number":["LY22H180001"]}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03215"],"award-info":[{"award-number":["2024C03215"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Municipal Natural Science Foundation of Beijing","award":["7222306"],"award-info":[{"award-number":["7222306"]}]},{"name":"National TCM innovation team and talent support projects","award":["ZYYCXTD-C-202210"],"award-info":[{"award-number":["ZYYCXTD-C-202210"]}]},{"name":"Hainan Province Science and Technology special fund","award":["ZDYF2022SHFZ292"],"award-info":[{"award-number":["ZDYF2022SHFZ292"]}]},{"name":"Hainan Province Clinical Medical Center","award":["QWYH2022341"],"award-info":[{"award-number":["QWYH2022341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01660-9","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T03:32:05Z","timestamp":1748230325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Approved trends and product characteristics of digital therapeutics in four countries"],"prefix":"10.1038","volume":"8","author":[{"given":"Jun","family":"Liang","sequence":"first","affiliation":[]},{"given":"Qichuan","family":"Fang","sequence":"additional","affiliation":[]},{"given":"Xiaoyi","family":"Jiao","sequence":"additional","affiliation":[]},{"given":"Peng","family":"Xiang","sequence":"additional","affiliation":[]},{"given":"Junhao","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Zijiao","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Yongcheng","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Yunfan","family":"He","sequence":"additional","affiliation":[]},{"given":"Yingjun","family":"Li","sequence":"additional","affiliation":[]},{"given":"Zhixu","family":"He","sequence":"additional","affiliation":[]},{"given":"Jianbo","family":"Lei","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2023.1086219","volume":"5","author":"A Watson","year":"2023","unstructured":"Watson, A., Chapman, R., Shafai, G. & Maricich, Y. A. FDA regulations and prescription digital therapeutics: evolving with the technologies they regulate. Front Digit Health 5, 1086219 (2023).","journal-title":"Front Digit Health"},{"key":"1660_CR2","doi-asserted-by":"publisher","first-page":"e19473","DOI":"10.2196\/19473","volume":"23","author":"S R Niakan Kalhori","year":"2021","unstructured":"R Niakan Kalhori, S. et al. Digital health solutions to control the COVID-19 pandemic in countries with high disease prevalence: literature review. J. Med Internet Res. 23, e19473 (2021).","journal-title":"J. Med Internet Res."},{"key":"1660_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/JPR.S387548","volume":"16","author":"X Chen","year":"2023","unstructured":"Chen, X. & Luo, Y. Digital therapeutics in migraine management: a novel treatment option in the COVID-19 Era. J. Pain. Res. 16, 111\u2013117 (2023).","journal-title":"J. Pain. Res."},{"key":"1660_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41746-023-00777-z","volume":"6","author":"C Wang","year":"2023","unstructured":"Wang, C., Lee, C. & Shin, H. Digital therapeutics from bench to bedside. NPJ Digit. Med. 6, 38 (2023).","journal-title":"NPJ Digit. Med."},{"key":"1660_CR5","unstructured":"Digital Therapeutics Alliance. DTA\u2019s Adoption & Interpretation of ISO\u2019s DTx Definition, https:\/\/dtxalliance.org\/wp-content\/uploads\/2023\/06\/DTA_FS_New-DTx-Definition.pdf (2023)."},{"key":"1660_CR6","doi-asserted-by":"publisher","first-page":"106319","DOI":"10.1016\/j.cmpb.2021.106319","volume":"209","author":"JS Hong","year":"2021","unstructured":"Hong, J. S., Wasden, C. & Han, D. H. Introduction of digital therapeutics. Comput. Methods Prog. Biomed. 209, 106319 (2021).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"1660_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/jch.14894","volume":"26","author":"C Chen","year":"2024","unstructured":"Chen, C., Liu, A., Zhang, Z., Chen, J. & Huang, H. Digital therapeutics in hypertension: how to make sustainable lifestyle changes. J. Clin. Hypertens. (Greenwich) 26, 1125\u20131132 (2024).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"1660_CR8","doi-asserted-by":"publisher","unstructured":"Seo, Y. C., Yong, S. Y., Choi, W. W. & Kim, S. H. Meta-analysis of studies on the effects of digital therapeutics. J. Pers. Med. https:\/\/doi.org\/10.3390\/jpm14020157 (2024).","DOI":"10.3390\/jpm14020157"},{"key":"1660_CR9","unstructured":"US Food and Drug Administration. Digital Health Center of Excellence, https:\/\/www.fda.gov\/medical-devices\/digital-health-center-excellence#:~:text=Our%20objectives:%20The%20Digital%20Health%20Center%20of%20Excellence%20aims%20to (2020)."},{"key":"1660_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12962-022-00359-y","volume":"20","author":"D Gensorowsky","year":"2022","unstructured":"Gensorowsky, D., Witte, J., Batram, M. & Greiner, W. Market access and value-based pricing of digital health applications in Germany. Cost. Eff. Resour. Alloc. 20, 25 (2022).","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"1660_CR11","unstructured":"The People\u2019s Republic Of China. \u201cHealthy China 2030\u201d Initiative https:\/\/www.gov.cn\/zhengce\/2016-10\/25\/content_5124174.htm (2016)."},{"key":"1660_CR12","unstructured":"People\u2019s Government of Hainan Province. Notice of the General Office of the People\u2019s Government of Hainan Province on Issuing Several Measures to Accelerate the Development of Digital Therapeutics Industry in Hainan Province https:\/\/www.hainan.gov.cn\/hainan\/zmghnwj\/202210\/08fbc2fd68bb4c88835e3e111458b97b.shtml (2022)."},{"key":"1660_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10536","volume":"8","author":"P Phan","year":"2023","unstructured":"Phan, P., Mitragotri, S. & Zhao, Z. Digital therapeutics in the clinic. Bioeng. Transl. Med. 8, e10536 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"1660_CR14","doi-asserted-by":"publisher","first-page":"e48000","DOI":"10.2196\/48000","volume":"25","author":"R van Kessel","year":"2023","unstructured":"van Kessel, R. et al. Mapping factors that affect the uptake of digital therapeutics within health systems: scoping review. J. Med Internet Res. 25, e48000 (2023).","journal-title":"J. Med Internet Res."},{"key":"1660_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00415-021-10608-4","volume":"269","author":"G Abbadessa","year":"2022","unstructured":"Abbadessa, G. et al. Digital therapeutics in neurology. J. Neurol. 269, 1209\u20131224 (2022).","journal-title":"J. Neurol."},{"key":"1660_CR16","doi-asserted-by":"publisher","unstructured":"Li, S., Tao, J., Tang, J., Chu, Y. & Wu, H. Digital therapeutics as an emerging new therapy for diabetes mellitus: potentials and concerns. Endocr. Connect. https:\/\/doi.org\/10.1530\/ec-24-0219 (2024).","DOI":"10.1530\/ec-24-0219"},{"key":"1660_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1177\/19322968211017901","volume":"15","author":"Y Fundoiano-Hershcovitz","year":"2021","unstructured":"Fundoiano-Hershcovitz, Y. et al. Digital therapeutics for type 2 diabetes: incorporating coaching support and validating digital monitoring. J. Diab. Sci. Technol. 15, 1188\u20131189 (2021).","journal-title":"J. Diab. Sci. Technol."},{"key":"1660_CR18","first-page":"S437","volume":"26","author":"M Chalmers","year":"2023","unstructured":"Chalmers, M., Hughes, J., Samavedam, S. & Kanade, P. MT59 overview of approved digital therapeutics in Belgium. Value Health 26, S437 (2023).","journal-title":"Value Health"},{"key":"1660_CR19","first-page":"S437","volume":"26","author":"M Chalmers","year":"2023","unstructured":"Chalmers, M., Hughes, J., Rai, D. & Saini, R. MT60 digital health applications (DIGA) in Germany\u2014an observation of clinical evidence submissions. Value Health 26, S437\u2013S438 (2023).","journal-title":"Value Health"},{"key":"1660_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4070\/kcj.2022.0014","volume":"52","author":"JH Ju","year":"2022","unstructured":"Ju, J. H., Sim, B., Lee, J. & Lee, J. Y. Reimbursement of digital therapeutics: future perspectives in Korea. Korean Circ. J. 52, 265\u2013279 (2022).","journal-title":"Korean Circ. J."},{"key":"1660_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.4972","author":"M Amyx","year":"2024","unstructured":"Amyx, M., Phi, N. T. T., Alebouyeh, F., Ravaud, P. & Tran, V. T. Mapping the evidence supporting digital therapeutics: a review. JAMA Intern Med https:\/\/doi.org\/10.1001\/jamainternmed.2024.4972 (2024).","journal-title":"JAMA Intern Med"},{"key":"1660_CR22","doi-asserted-by":"publisher","first-page":"S292","DOI":"10.1016\/j.jval.2023.09.1543","volume":"26","author":"J Tokarska","year":"2023","unstructured":"Tokarska, J., Foxon, G., Zakrzewska, K. & Craddy, P. PT21 evaluation and reimbursement of digital therapeutics in Germany, France, Belgium and England. Value Health 26, S292 (2023).","journal-title":"Value Health"},{"key":"1660_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2021.1966187","volume":"9","author":"FF Velez","year":"2021","unstructured":"Velez, F. F. & Malone, D. C. Cost-effectiveness analysis of a prescription digital therapeutic for the treatment of opioid use disorder. J. Mark. Access Health Policy 9, 1966187 (2021).","journal-title":"J. Mark. Access Health Policy"},{"key":"1660_CR24","unstructured":"Federal Institute for Drugs and Medical Devices. Find the Right Digital Health Application https:\/\/diga.bfarm.de\/de\/verzeichnis?type=%5B%5D (2024)."},{"key":"1660_CR25","unstructured":"mHealthBELGIUM. All Applications https:\/\/mhealthbelgium.be\/apps (2024)."},{"key":"1660_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/21582440211052555","volume":"11","author":"G Dambiski Gomes de Carvalho","year":"2021","unstructured":"Dambiski Gomes de Carvalho, G., Resende, L. M. M., Pontes, J., Gomes de Carvalho, H. & Mendes Betim, L. Innovation and management in MSMEs: a literature review of highly cited papers. Sage Open 11, 21582440211052555 (2021).","journal-title":"Sage Open"},{"key":"1660_CR27","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1038\/d41586-019-02873-1","volume":"573","author":"S Makin","year":"2019","unstructured":"Makin, S. The emerging world of digital therapeutics. Nature 573, S106\u2013s109 (2019).","journal-title":"Nature"},{"key":"1660_CR28","unstructured":"US Food and Drug Administration. Digital Health Innovation Action Plan [phttps:\/\/www.fda.gov\/media\/106331\/download (2017)."},{"key":"1660_CR29","unstructured":"US Food and Drug Administration. The Software Precertification (Pre-Cert) Pilot Program: Tailored Total Product Lifecycle Approaches and Key Findings https:\/\/www.fda.gov\/media\/161815\/download (2017)."},{"key":"1660_CR30","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s12247-023-09767-w","volume":"18","author":"A Romagnoli","year":"2023","unstructured":"Romagnoli, A. et al. The developmpent of digital therapies as a new therapeutic option to treat diseases: focus on the international regulatory framework. J. Pharm. Innov. 18, 2447\u20132458 (2023).","journal-title":"J. Pharm. Innov."},{"key":"1660_CR31","first-page":"685","volume":"29","author":"M Salsabili","year":"2023","unstructured":"Salsabili, M. et al. Prescription digital therapeutics: applying medicaid experience to value assessment and formulary management. J. Manag Care Spec. Pharm. 29, 685\u2013691 (2023).","journal-title":"J. Manag Care Spec. Pharm."},{"key":"1660_CR32","unstructured":"Hagen, J. Pear Therapeutics Files for Bankruptcy https:\/\/www.mobihealthnews.com\/news\/pear-therapeutics-files-bankruptcy (2023)."},{"key":"1660_CR33","unstructured":"Businesswire. Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq https:\/\/www.businesswire.com\/news\/home\/20240314953259\/en\/Better-Therapeutics-Announces-it-will-Seek-Strategic-Alternatives-and-will-be-Delisted-from-Nasdaq (2024)."},{"key":"1660_CR34","unstructured":"Stocktitan. Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive https:\/\/www.stocktitan.net\/news\/AKLI\/virtual-therapeutics-announces-results-of-tender-offer-to-acquire-zo6fkqt78zvv.html (2024)."},{"key":"1660_CR35","unstructured":"Hunan Medical Products Administration. Hunan Provincial Drug Administration on the Implementation of the Second and Third Class of Medical Devices Production License Throughout the Paperless Online Processing Announcement (2021 No. 10) https:\/\/mpa.hunan.gov.cn\/mpa\/xxgk\/tzgg\/wjtz\/202103\/15267438\/files\/454ade58b2b5492692fa2f80b9eacd07.doc (2021)."},{"key":"1660_CR36","volume":"8","author":"F Dahlhausen","year":"2022","unstructured":"Dahlhausen, F. et al. There\u2019s an app for that, but nobody\u2019s using it: Insights on improving patient access and adherence to digital therapeutics in Germany. Digit Health 8, 20552076221104672 (2022).","journal-title":"Digit Health"},{"key":"1660_CR37","volume":"8","author":"S Frey","year":"2022","unstructured":"Frey, S. & Kerkemeyer, L. Acceptance of digital health applications in non-pharmacological therapies in German statutory healthcare system: results of an online survey. Digit Health 8, 20552076221131142 (2022).","journal-title":"Digit Health"},{"key":"1660_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41746-024-01137-1","volume":"7","author":"L Schmidt","year":"2024","unstructured":"Schmidt, L., Pawlitzki, M., Renard, B. Y., Meuth, S. G. & Masanneck, L. The three-year evolution of Germany\u2019s Digital Therapeutics reimbursement program and its path forward. NPJ Digit Med. 7, 139 (2024).","journal-title":"NPJ Digit Med."},{"key":"1660_CR39","unstructured":"National Health Commission of the People\u2019s Republic of China. Letter in Response to Proposal No. 03019 of the Second Session of the 14th National Committee of the Chinese People\u2019s Political Consultative Conference (Health and Medical Category No. 229); http:\/\/www.nhc.gov.cn\/wjw\/tia\/202409\/50b5516e5d094c36a95b69d8f32abc08.shtml (2024)."},{"key":"1660_CR40","unstructured":"Ministry of Civil Affairs of the People\u2019s Republic of China. State Bulletin on Aging 2023 Released https:\/\/www.mca.gov.cn\/n152\/n166\/c1662004999980001780\/content.html (2024)."},{"key":"1660_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.32481\/djph.2022.12.043","volume":"8","author":"T Gibbs","year":"2022","unstructured":"Gibbs, T. & Sabine, N. Chronic disease management and the healthcare workforce. Dela J. Public Health 8, 176\u2013196 (2022).","journal-title":"Dela J. Public Health"},{"key":"1660_CR42","unstructured":"American Medical Association. How New Medical Codes can Boost Use of Digital Therapeutic Tools https:\/\/www.ama-assn.org\/practice-management\/cpt\/how-new-medical-codes-can-boost-use-digital-therapeutic-tools (2022)."},{"key":"1660_CR43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/TCRM.S489873","volume":"20","author":"A Fassbender","year":"2024","unstructured":"Fassbender, A. et al. Adoption of digital therapeutics in Europe. Ther. Clin. Risk Manag. 20, 939\u2013954 (2024).","journal-title":"Ther. Clin. Risk Manag."},{"key":"1660_CR44","unstructured":"Health Innovation Oxford & Thames Valley. How to Successfully Bring Digital Therapeutics to the NHS, https:\/\/www.healthinnovationoxford.org\/news-and-events\/news\/how-to-bring-digital-therapeutics-to-the-nhs\/ (2025)."},{"key":"1660_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11286-4","volume":"24","author":"J Kim","year":"2024","unstructured":"Kim, J. et al. Understanding patient perspectives on digital therapeutics and its platform for insomnia: insights from focused group interviews. BMC Health Serv. Res. 24, 859 (2024).","journal-title":"BMC Health Serv. Res."},{"key":"1660_CR46","doi-asserted-by":"publisher","first-page":"e55199","DOI":"10.2196\/55199","volume":"12","author":"Y He","year":"2024","unstructured":"He, Y. et al. Mining user reviews from hypertension management mobile health apps to explore factors influencing user satisfaction and their asymmetry: comparative study. JMIR Mhealth Uhealth 12, e55199 (2024).","journal-title":"JMIR Mhealth Uhealth"},{"key":"1660_CR47","doi-asserted-by":"publisher","first-page":"e48027","DOI":"10.2196\/48027","volume":"12","author":"A Chaves","year":"2024","unstructured":"Chaves, A., Arn\u00e1ez, S. & Garc\u00eda-Soriano, G. The effectiveness of a cell phone eHealth App in changing knowledge, stigmatizing attitudes, and intention to seek help associated with obsessive-compulsive disorder: pilot questionnaire study. JMIR Mhealth Uhealth 12, e48027 (2024).","journal-title":"JMIR Mhealth Uhealth"},{"key":"1660_CR48","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.4103\/jfmpc.jfmpc_1252_20","volume":"9","author":"T Kamat","year":"2020","unstructured":"Kamat, T. Digital therapeutics can improve medication adherence in diabetes. J. Fam. Med. Prim. Care 9, 5806\u20135807 (2020).","journal-title":"J. Fam. Med. Prim. Care"},{"key":"1660_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1488687","volume":"12","author":"S Kyriazakos","year":"2024","unstructured":"Kyriazakos, S. et al. Benchmarking the clinical outcomes of Healthentia SaMD in chronic disease management: a systematic literature review comparison. Front. Public Health 12, 1488687 (2024).","journal-title":"Front. Public Health"},{"key":"1660_CR50","unstructured":"Smartpatient gmbh. DTx Regulations: How France Will Follow Germany\u2019s Lead for Digital Therapeutics Reimbursement https:\/\/www.smartpatient.eu\/blog\/digital-therapeutics-dtx-regulation-france-following-germanys-diga-model# (2021)."},{"key":"1660_CR51","first-page":"313","volume":"30","author":"AG Lumbreras","year":"2024","unstructured":"Lumbreras, A. G. et al. Insights into insurance coverage for digital therapeutics: a qualitative study of US payer perspectives. J. Manag Care Spec. Pharm. 30, 313\u2013325 (2024).","journal-title":"J. Manag Care Spec. Pharm."},{"key":"1660_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241277441","volume":"10","author":"P Armeni","year":"2024","unstructured":"Armeni, P. et al. Exploring the potential of digital therapeutics: an assessment of progress and promise. Digit Health 10, 20552076241277441 (2024).","journal-title":"Digit Health"},{"key":"1660_CR53","first-page":"6418","volume":"26","author":"P Refolo","year":"2022","unstructured":"Refolo, P., Sacchini, D., Raimondi, C. & Spagnolo, A. G. Ethics of digital therapeutics (DTx). Eur. Rev. Med Pharm. Sci. 26, 6418\u20136423 (2022).","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"1660_CR54","doi-asserted-by":"publisher","first-page":"e60773","DOI":"10.2196\/60773","volume":"26","author":"Y He","year":"2024","unstructured":"He, Y. et al. Establishing an evaluation indicator system for user satisfaction with hypertension management apps: combining user-generated content and analytic hierarchy process. J. Med. Internet Res. 26, e60773 (2024).","journal-title":"J. Med. Internet Res."},{"key":"1660_CR55","doi-asserted-by":"publisher","first-page":"e42856","DOI":"10.2196\/42856","volume":"25","author":"M Nuo","year":"2023","unstructured":"Nuo, M. et al. Mining the influencing factors and their asymmetrical effects of mhealth sleep App user satisfaction from real-world user-generated reviews: content analysis and topic modeling. J. Med Internet Res. 25, e42856 (2023).","journal-title":"J. Med Internet Res."},{"key":"1660_CR56","doi-asserted-by":"publisher","first-page":"e2215014","DOI":"10.1001\/jamanetworkopen.2022.15014","volume":"5","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Use of machine learning to mine user-generated content from mobile health apps for weight loss to assess factors correlated with user satisfaction. JAMA Netw. Open 5, e2215014 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1660_CR57","doi-asserted-by":"publisher","first-page":"e0303302","DOI":"10.1371\/journal.pone.0303302","volume":"19","author":"A Carrera","year":"2024","unstructured":"Carrera, A. et al. Therapies go digital. What drives physicians\u2019 acceptance?. PLoS One 19, e0303302 (2024).","journal-title":"PLoS One"},{"key":"1660_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13098-022-00818-9","volume":"14","author":"M Rassi-Cruz","year":"2022","unstructured":"Rassi-Cruz, M., Valente, F. & Caniza, M. V. Digital therapeutics and the need for regulation: how to develop products that are innovative, patient-centric and safe. Diabetol. Metab. Syndr. 14, 48 (2022).","journal-title":"Diabetol. Metab. Syndr."},{"key":"1660_CR59","doi-asserted-by":"publisher","unstructured":"Biskupiak, Z., Ha, V. V., Rohaj, A. & Bulaj, G. Digital therapeutics for improving effectiveness of pharmaceutical drugs and biological products: preclinical and clinical studies supporting development of Drug + Digital combination therapies for chronic diseases. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13020403 (2024).","DOI":"10.3390\/jcm13020403"},{"key":"1660_CR60","unstructured":"US Food and Drug Administration. Guidances with Digital Health Content https:\/\/www.fda.gov\/medical-devices\/digital-health-center-excellence\/guidances-digital-health-content (2025)."},{"key":"1660_CR61","unstructured":"National Medical Products Administration of the China. National Medical Products Administration data query https:\/\/www.nmpa.gov.cn\/datasearch\/home-index.html?3jfdxVGGVXFo=1687243375503#category=ylqx (2024)."},{"key":"1660_CR62","unstructured":"US Food and Drug Administration. Search Medical Device Databases https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices (2024)."},{"key":"1660_CR63","unstructured":"Digital Therapeutics Alliance. Product Library https:\/\/dtxalliance.org\/understanding-dtx\/product-library\/ (2024)."},{"key":"1660_CR64","unstructured":"VBData. https:\/\/www.vbdata.cn\/ (2024)."},{"key":"1660_CR65","unstructured":"Digital Therapeutics Alliance. DTx Product Categories https:\/\/dtxalliance.org\/wp-content\/uploads\/2021\/01\/DTA_FS_DTx-Product-Categories_010521.pdf (2021)."},{"key":"1660_CR66","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41440-023-01317-8","volume":"46","author":"A Nomura","year":"2023","unstructured":"Nomura, A. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan. Hypertens. Res. 46, 2126\u20132134 (2023).","journal-title":"Hypertens. Res."},{"key":"1660_CR67","unstructured":"World Health Organization. ICD-10 Version:2019 https:\/\/icd.who.int\/browse10\/2019\/en (2019)."},{"key":"1660_CR68","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2589-7500(20)30292-2","volume":"3","author":"UJ Muehlematter","year":"2021","unstructured":"Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit. Health 3, e195\u2013e203 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1660_CR69","doi-asserted-by":"publisher","unstructured":"Komatsu, M. et al. Towards clinical application of artificial intelligence in ultrasound imaging. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9070720 (2021).","DOI":"10.3390\/biomedicines9070720"},{"key":"1660_CR70","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s42256-021-00386-z","volume":"3","author":"KN Vokinger","year":"2021","unstructured":"Vokinger, K. N. & Gasser, U. Regulating AI in medicine in the United States and Europe. Nat. Mach. Intell. 3, 738\u2013739 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"1660_CR71","doi-asserted-by":"publisher","unstructured":"Lyell, D., Coiera, E., Chen, J., Shah, P. & Magrabi, F. How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices. BMJ Health Care Inform. https:\/\/doi.org\/10.1136\/bmjhci-2020-100301 (2021).","DOI":"10.1136\/bmjhci-2020-100301"},{"key":"1660_CR72","unstructured":"Ministry of Food and Drug Safety, South Korea. Regulations https:\/\/www.mfds.go.kr\/eng\/brd\/m_40\/view.do?seq=72624&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1 (2020)."},{"key":"1660_CR73","unstructured":"Digitale-Versorgung-Gesetz. The Fast-Track Process for Digital Health Applications (DiGA) According to Section 139e SGB V. A Guide for Manufacturers, Service Providers and Users https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/EN\/MedicalDevices\/DiGA_Guide.html (2020)."},{"key":"1660_CR74","unstructured":"Vcbeat.top & VCBeat Research. China Digital Therapeutics White Paper (2021 Edition) https:\/\/cdn.vcbeat.top\/upload\/report\/47\/96\/22\/21\/607fea2e49222.pdf (2021)."},{"key":"1660_CR75","unstructured":"US Food and Drug Administration. US Policy for Device\/Software Functions and Mobile Medical Applications https:\/\/www.fda.gov\/media\/80958\/download (2022)."},{"key":"1660_CR76","unstructured":"European Data Protection Supervisor. Digital Therapeutics (DTx) https:\/\/www.edps.europa.eu\/press-publications\/publications\/techsonar\/digital-therapeutics-dtx_en (2023)."},{"key":"1660_CR77","unstructured":"Ministry of Health, Labour and Welfare of Japan. Guidelines for medical device applicability of the program https:\/\/www.mhlw.go.jp\/content\/11120000\/000764274.pdf (2021)."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01660-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:02:51Z","timestamp":1748235771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01660-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01660-9","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}